GB1356912A - Radioiodinated derivatives of carcinoembryonic antigen materials and processes for the production thereof - Google Patents

Radioiodinated derivatives of carcinoembryonic antigen materials and processes for the production thereof

Info

Publication number
GB1356912A
GB1356912A GB4418473A GB4418473A GB1356912A GB 1356912 A GB1356912 A GB 1356912A GB 4418473 A GB4418473 A GB 4418473A GB 4418473 A GB4418473 A GB 4418473A GB 1356912 A GB1356912 A GB 1356912A
Authority
GB
United Kingdom
Prior art keywords
processes
production
carcinoembryonic antigen
radioiodinated
antigen materials
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB4418473A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Publication of GB1356912A publication Critical patent/GB1356912A/en
Expired legal-status Critical Current

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J47/00—Ion-exchange processes in general; Apparatus therefor
    • B01J47/02—Column or bed processes
    • B01J47/04—Mixed-bed processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/10—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
    • A61K51/1045—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against animal or human tumor cells or tumor cell determinants
    • A61K51/1048—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against animal or human tumor cells or tumor cell determinants the tumor cell determinant being a carcino embryonic antigen
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J39/00—Cation exchange; Use of material as cation exchangers; Treatment of material for improving the cation exchange properties
    • B01J39/26—Cation exchangers for chromatographic processes
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J47/00—Ion-exchange processes in general; Apparatus therefor
    • B01J47/014—Ion-exchange processes in general; Apparatus therefor in which the adsorbent properties of the ion-exchanger are involved, e.g. recovery of proteins or other high-molecular compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C07K16/3007—Carcino-embryonic Antigens
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57473—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving carcinoembryonic antigen, i.e. CEA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2123/00—Preparations for testing in vivo
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/804—Radioisotope, e.g. radioimmunoassay
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/811—Test for named disease, body condition or organ function
    • Y10S436/813—Cancer
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/825—Pretreatment for removal of interfering factors from sample
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/806—Antigenic peptides or proteins
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/828—Cancer

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • Hospice & Palliative Care (AREA)
  • Animal Behavior & Ethology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Microbiology (AREA)
  • Optics & Photonics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

1356912 Radioiodinated carcinoembryonic antigens F HOFFMANN-LA ROCHE & CO AG 1 June 1971 [1 June 1970 27 Jan 1971 12 April 1971] 44184/73 Divided out of 1356911 Heading A5B The components A and B into which carcinoembryonic antigen has been separated by the process of the parent Specification may be "tagged" with I<SP>125</SP> by radioiodination by conventional procedures, e.g. the "Chloramine T" method.
GB4418473A 1970-06-01 1971-06-01 Radioiodinated derivatives of carcinoembryonic antigen materials and processes for the production thereof Expired GB1356912A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US4252670A 1970-06-01 1970-06-01
US11028871A 1971-01-27 1971-01-27
US13340471A 1971-04-12 1971-04-12

Publications (1)

Publication Number Publication Date
GB1356912A true GB1356912A (en) 1974-06-19

Family

ID=27366145

Family Applications (4)

Application Number Title Priority Date Filing Date
GB4418573A Expired GB1358827A (en) 1970-06-01 1971-06-01 Process for detecting the presence of human carcinoembryonic antigen material in blood
GB1830971*[A Expired GB1356911A (en) 1970-06-01 1971-06-01 Purification and fractionation of carcinoembryonic antigen
GB4418473A Expired GB1356912A (en) 1970-06-01 1971-06-01 Radioiodinated derivatives of carcinoembryonic antigen materials and processes for the production thereof
GB4418773A Expired GB1358828A (en) 1970-06-01 1971-06-01 Process for detecting the presence of human carcinoembryonic antigen material or component a or b thereof in blood

Family Applications Before (2)

Application Number Title Priority Date Filing Date
GB4418573A Expired GB1358827A (en) 1970-06-01 1971-06-01 Process for detecting the presence of human carcinoembryonic antigen material in blood
GB1830971*[A Expired GB1356911A (en) 1970-06-01 1971-06-01 Purification and fractionation of carcinoembryonic antigen

Family Applications After (1)

Application Number Title Priority Date Filing Date
GB4418773A Expired GB1358828A (en) 1970-06-01 1971-06-01 Process for detecting the presence of human carcinoembryonic antigen material or component a or b thereof in blood

Country Status (13)

Country Link
US (1) US3697638A (en)
JP (1) JPS542247B1 (en)
BE (1) BE767801A (en)
CA (1) CA965351A (en)
CH (4) CH596554A5 (en)
DE (1) DE2126680B2 (en)
DK (1) DK132739C (en)
FR (1) FR2095644A5 (en)
GB (4) GB1358827A (en)
IL (1) IL36950A (en)
IT (1) IT998033B (en)
NL (1) NL161457C (en)
SE (5) SE400083B (en)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3867363A (en) * 1970-06-01 1975-02-18 Hans John Hansen Carcinoembryonic antigens
US3956258A (en) * 1972-05-12 1976-05-11 Hoffmann-La Roche Inc. Carcinoembryonic antigens
CH583036A5 (en) * 1972-05-12 1976-12-31 Hoffmann La Roche
ZA723264B (en) * 1972-10-13 1974-08-28 H Van Til Improvements in toys
US3867518A (en) * 1973-03-09 1975-02-18 Hoffmann La Roche Radioimmunoassay for insulin
US3927193A (en) * 1973-05-18 1975-12-16 Hoffmann La Roche Localization of tumors by radiolabelled antibodies
US4022876A (en) * 1973-06-21 1977-05-10 Stanford Research Institute Mass spectrometric immunoassay
US4132769A (en) * 1974-10-30 1979-01-02 Osther Kurt B Cancer antigen, cancer therapy, and cancer diagnosis
US4152410A (en) * 1975-09-03 1979-05-01 Eisai Co., Ltd. Diagnosis reagent for neoplasm and method for diagnosis of neoplasm
US4132767A (en) * 1976-04-05 1979-01-02 Eisai Co., Ltd. Preparation of α-L antibody, purification of α-L antigen and reagent for detection of α-L antibody and α-L antigen
US4144031A (en) * 1976-04-19 1979-03-13 International Radioimmune Systems, Inc. Cell test for detecting human chorionic gonadotropin
US4145336A (en) * 1976-04-30 1979-03-20 Scripps Clinic And Research Foundation Carcinoembryonic antigen isomer
US4140753A (en) * 1976-04-30 1979-02-20 Scripps Clinic & Research Foundation Diagnostic method and reagent
US4146603A (en) * 1977-02-18 1979-03-27 Research Corporation Tumor specific glycoproteins and method for detecting tumorigenic cancers
US4234476A (en) * 1978-03-07 1980-11-18 Research Corporation Application of protein-protein interaction as an assay for the detection of cancer
US4228127A (en) * 1978-10-06 1980-10-14 International Radioimmune Systems, Inc. Kit for detecting human chorionic gonadotropin
US4241044A (en) * 1978-12-28 1980-12-23 Abbott Laboratories Method of diagnosing cancer by detecting elevated anti-T antibody activity
US4349528A (en) * 1979-11-21 1982-09-14 The Wistar Institute Monocolonal hybridoma antibody specific for high molecular weight carcinoembryonic antigen
US4299815A (en) * 1980-02-08 1981-11-10 Hoffmann-La Roche Inc. Carcinoembryonic antigen determination
US4578349A (en) * 1982-04-08 1986-03-25 Abbott Laboratories Immunoassay for carcinoembryonic antigen (CEA)
ATE28937T1 (en) * 1982-08-09 1987-08-15 Centocor Inc IMMUNOTEST FOR CARBOHYDRATE ANTIGEN DETERMINANT.
DK557483A (en) * 1982-12-06 1984-06-07 Hoffmann La Roche METHOD OF DETERMINING CEA
US4962187A (en) * 1984-11-28 1990-10-09 Cota Biotech Common antigen for colorectal and mucinous ovarian tumors and process for isolating the same
US5030559A (en) * 1986-04-01 1991-07-09 Board Of Regents, The University Of Texas System Methods and compositions for the identification of metastatic human tumors
US6022958A (en) * 1986-08-13 2000-02-08 Bayer Corporation cDNAs coding for members of the carcinoembryonic antigen family
US5217903A (en) * 1990-05-15 1993-06-08 Trustees Of Boston University Measuring connective tissue breakdown products in body fluids

Also Published As

Publication number Publication date
IL36950A (en) 1975-04-25
SE419482B (en) 1981-08-03
DE2126680A1 (en) 1971-12-09
GB1358828A (en) 1974-07-03
DK132739C (en) 1976-07-12
FR2095644A5 (en) 1972-02-11
DE2126680B2 (en) 1980-10-09
IL36950A0 (en) 1971-11-29
GB1358827A (en) 1974-07-03
SE7413186L (en) 1974-10-18
CH596554A5 (en) 1978-03-15
SE419481B (en) 1981-08-03
CH604665A5 (en) 1978-09-15
CA965351A (en) 1975-04-01
JPS542247B1 (en) 1979-02-05
SE421425B (en) 1981-12-21
SE7413184L (en) 1974-10-18
CH606067A5 (en) 1978-10-13
SE400083B (en) 1978-03-13
SE7413187L (en) 1974-10-18
US3697638A (en) 1972-10-10
NL161457B (en) 1979-09-17
SE7413185L (en) 1974-10-18
IT998033B (en) 1976-01-20
DK132739B (en) 1976-02-02
NL7107499A (en) 1971-12-03
GB1356911A (en) 1974-06-19
NL161457C (en) 1980-02-15
CH595636A5 (en) 1978-02-15
BE767801A (en) 1971-11-29
SE397139B (en) 1977-10-17

Similar Documents

Publication Publication Date Title
GB1356912A (en) Radioiodinated derivatives of carcinoembryonic antigen materials and processes for the production thereof
GB1322000A (en) Preparation of antiserum specific for a carcinoembryonic antigen
GB1132083A (en) A novel thymine derivative and a process for the preparation thereof
AU476619B2 (en) Method of detecting antigens or antibodies
ATA399781A (en) Process and reaction mixture for detecting antibodies, and process for producing the reaction mixture
NL172327C (en) METHOD FOR THE PREPARATION OR MANUFACTURE OF A PREPARATION WITH BACTERIA ANTI-ACTION AND PROCESS FOR THE PREPARATION OF A 7-BETA (SUBSTITUTED ACETAMIDO) -7-ALFA-METHOXYTHOLETHYLETHYLETHYLETHYLETHYLETHYLETHYLETHYLETHYLETHYLETHYLETHYLETHYLETHYLETHYL]
OA03866A (en) Explosive composition, process for activating and firing an explosive and envelope for the explosive.
GB1436336A (en) Electrostatic recording method and apparatus
NL7610853A (en) METHOD FOR DETERMINING HEPATITIS B NUCLEAR ANTIGEN OR HEPATITIS ANTIGEN, RESPECTIVELY OF THE CORRESPONDING ANTIBODIES AND PREPARATION FOR INDUCING THE FORMATION OF ANTIBODIES CONTAINING A CROSS REACTION.
NL7604298A (en) METHOD AND ESTABLISHMENT FOR THE CONTINUOUS PRODUCTION OF STANDARDIZED MILK AS WELL AS STANDARDIZED MILK MANUFACTURED BY THE PROCESS.
CA1012661A (en) Method for the analysis of isotopes
CA952285A (en) Method for the production of chlorine monoxide gas
GB1416544A (en) Immunizing agents for bacterial infections
CA941726A (en) Method and apparatus for the production of tube
IL37581A (en) A method for producing the methane oxidizing bacterial strain&#34;m 102&#34;and a method for synthesizing protein with it
AU2871771A (en) 4,5, &amp; - oxido-bufa-dienolido-3- [rhamnosido-2&#39;,3&#39;-dialkylortho-carbonates] and process for their manufacture
RO67383A (en) PROCESS FOR THE PREPARATION OF 2,4-DIAMINO-5-BENZYLPIRIMIDINE
NL175416C (en) PROCESS FOR THE PREPARATION OF PHARMACEUTICAL PREPARATIONS WITH ANTI-COMPULSORY ACTION, THE PHARMACEUTICAL PREPARATIONS OBTAINED THEREOF, AND METHOD FOR THE PREPARATION OF ANHYDRO-2-MERCAPHYDROXYDYL-1,3,4-THL-HYDROZOL-1,3,4
NL163507C (en) PROCESS FOR PREPARING A PHARMACEUTICAL PREPARATION WITH PREGNANCY PREPARATION BASED ON PGE &amp; 012 AND PGF &amp; 012ALFA DERIVATIVES, AND METHOD FOR PREPARING PGE &amp; 012 DERIVATIVES AND P12 &amp; 012 DERIVATIVES THEREIN
AU465816B2 (en) Means, method and material for fabricating tapered tubing
CA842760A (en) Stabilized antigens and means for the production thereof
CA908157A (en) PROCESS FOR PREPARING USEFUL 17.alpha.-HYDROXY-20-KETO AND 17.alpha., 21-DIHYDROXY-20-KETO PREGNANES AND DERIVATIVES AND INTERMEDIATES THEREOF
CA709852A (en) 9.alpha.,16-DIFLUORO COMPOUNDS OF THE PREGNANE SERIES AND PROCESS FOR THE PRODUCTION THEREOF
CA859162A (en) Process for the preparation of hexahydro-1,2,4-triazine-3-thiones
GB1180813A (en) Novel Indole Derivatives

Legal Events

Date Code Title Description
PS Patent sealed [section 19, patents act 1949]
PCNP Patent ceased through non-payment of renewal fee